INFRMA-HC; 2 edition | May 1, 2008 | ISBN-10: 1420_0659_55 | 824 pages | PDF | 39 MB
Maintaining the first edition’s unique parallel to the strategy used by pathologists and pulmonologists to arrive at a patient’s diagnosis in daily practice, Diagnostic Pulmonary Pathology starts with the patient and their biopsy findings, directing the pathologist or clinician to the proper diagnosis. With many advances in pulmonary pathology, radiology, and pulmonary medicine, this new edition provides thorough updates in:
progress in classification and diagnosis of interstitial lung diseases
evolution of our understanding of pre-neoplastic lesions
technology in histopathology
molecular pathology
thoracic radiology
Written by contributing doctors who are at the forefront of recent advancements, Diagnostic Pulmonary Pathology:
is organized based on how the patient should be approached, and the patient’s own projections, signs, symptoms, and disease
provides new imaging techniques and molecular diagnostic tests
investigates the new classification schemes, i.e. classification and terminology for lung neoplasms, pulmonary hypertension, and lung transplant rejection
Maintaining the first edition’s unique parallel to the strategy used by pathologists and pulmonologists to arrive at a patient’s diagnosis in daily practice, Diagnostic Pulmonary Pathology starts with the patient and their biopsy findings, directing the pathologist or clinician to the proper diagnosis. With many advances in pulmonary pathology, radiology, and pulmonary medicine, this new edition provides thorough updates in:
progress in classification and diagnosis of interstitial lung diseases
evolution of our understanding of pre-neoplastic lesions
technology in histopathology
molecular pathology
thoracic radiology
Written by contributing doctors who are at the forefront of recent advancements, Diagnostic Pulmonary Pathology:
is organized based on how the patient should be approached, and the patient’s own projections, signs, symptoms, and disease
provides new imaging techniques and molecular diagnostic tests
investigates the new classification schemes, i.e. classification and terminology for lung neoplasms, pulmonary hypertension, and lung transplant rejection